<--- Back to Details
First PageDocument Content
Spectrum Pharmaceuticals / Drug development / Ibritumomab tiuxetan / Triple-negative breast cancer
Date: 2016-06-03 11:22:57
Spectrum Pharmaceuticals
Drug development
Ibritumomab tiuxetan
Triple-negative breast cancer

MARKET SNAPSHOT Stock priceweek range Market capitalization Shares outstanding Institutional ownership

Add to Reading List

Source URL: www.casipharmaceuticals.com

Download Document from Source Website

File Size: 413,22 KB

Share Document on Facebook

Similar Documents